Journal of gastroenterology and hepatology · 2026
The Malaysian Society of Gastroenterology and Hepatology Consensus Statements on Prevention and Early Detection of Hepatocellular Carcinoma in Malaysia.
СтатьяConsensus StatementОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lau Su Yin, Kok Victoria Sinq-Ling, Tan Soek-Siam, Adnan Syuhada Dan, Ng Wei-Lin, Ang Ban-Hong, Yaacob Nur Yazmin, Lee Yeong Yeh, Kaur Senamjit, Mohamed Rosmawati, Wong Ping-Foo, Lim Lee-Ling, Letchumanan Mohana, Vethakkan Shireene Ratna, Noor Nurain Mohd, Tan Siow-Foon, Low Tiong-Lim, Kiew Lee-Boon, Chan Wah-Kheong
Аннотация
BACKGROUND: Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related deaths in Malaysia. Early detection increases the likelihood of curative treatment and improves survival. This consensus document aims to provide evidence-based, locally relevant recommendations for the prevention and early detection of HCC.
METHODS: Nineteen experts from gastroenterology and hepatology, radiology, endocrinology, and family medicine were convened by the Malaysian Society of Gastroenterology and Hepatology. A modified Delphi method was used to prepare the consensus statements.
RESULTS: Twenty-two out of 26 statements achieved consensus and are included in this document. These statements addressed HCC prevention, risk stratification, surveillance strategies, barriers to effective surveillance, and recommendations on linkage to specialized hepatology care. Preventive measures include universal Hepatitis B vaccination for newborns, treatment of Hepatitis B and C, and lifestyle modification. Six-monthly surveillance with ultrasound and serum alpha-fetoprotein (AFP) is the current standard of care; however, adjunctive novel biomarkers and imaging can improve early HCC detection. Early identification of at-risk patients using noninvasive fibrosis assessment in the primary healthcare and endocrinology setting are equally important.
CONCLUSION: Active surveillance of at-risk patients is crucial in improving early HCC detection and patient survival. The efficacy of HCC surveillance requires greater awareness, better identification of at-risk patients and clear referral pathways, supported by multidisciplinary collaboration. This consensus document provides a practical, evidence-based approach to optimizing HCC prevention and early detection, with the goal of improving patient outcomes.
METHODS: Nineteen experts from gastroenterology and hepatology, radiology, endocrinology, and family medicine were convened by the Malaysian Society of Gastroenterology and Hepatology. A modified Delphi method was used to prepare the consensus statements.
RESULTS: Twenty-two out of 26 statements achieved consensus and are included in this document. These statements addressed HCC prevention, risk stratification, surveillance strategies, barriers to effective surveillance, and recommendations on linkage to specialized hepatology care. Preventive measures include universal Hepatitis B vaccination for newborns, treatment of Hepatitis B and C, and lifestyle modification. Six-monthly surveillance with ultrasound and serum alpha-fetoprotein (AFP) is the current standard of care; however, adjunctive novel biomarkers and imaging can improve early HCC detection. Early identification of at-risk patients using noninvasive fibrosis assessment in the primary healthcare and endocrinology setting are equally important.
CONCLUSION: Active surveillance of at-risk patients is crucial in improving early HCC detection and patient survival. The efficacy of HCC surveillance requires greater awareness, better identification of at-risk patients and clear referral pathways, supported by multidisciplinary collaboration. This consensus document provides a practical, evidence-based approach to optimizing HCC prevention and early detection, with the goal of improving patient outcomes.